Open-label Extension for Phase 3 Clinical Trials of Simufilam
Stopped early · Phase 3
Conditions studied: Alzheimer Disease
In brief
The goal of this open-label extension study is to assess long-term safety and tolerability of simufilam 100 mg in subjects who have completed the RETHINK-ALZ or REFOCUS-ALZ Phase 3 clinical trials.
Key facts
- Study ID
- NCT05575076
- Run by
- Cassava Sciences, Inc.
- People needed
- 1081
- Starts
- 2022-11-07
- Expected to finish
- 2025-01-31
- Last updated by the study team
- 2025-05-23
Who can join
Age: 51 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Residence in a skilled nursing facility requiring 24-hour care.
- Evidence of a neurologic condition other than AD that significantly contributes to the subject's dementia.
- Current clinically significant psychiatric diagnosis other than AD.
- Unstable, clinically significant medical condition other than AD.
- Any medical condition that in the opinion of the investigator may affect safety or ability to complete the study.
Where it is running
- CCT Research - Gilbert Neurology Partners — Gilbert, Arizona, United States
- Xenoscience, Inc. — Phoenix, Arizona, United States
- Banner Alzheimer's Institute — Phoenix, Arizona, United States
- Banner Sun Health Research Institute — Sun City, Arizona, United States
- Advanced Research Center, Inc. — Anaheim, California, United States
- North County Neurology Associates — Carlsbad, California, United States
- Axiom Research, LLC — Colton, California, United States
- ATP Clinical Research, Inc. — Costa Mesa, California, United States
- Neuro-Pain Medical Center — Fresno, California, United States
- Neurology Center of North Orange County — Fullerton, California, United States
- Sun Valley Research Center, Inc. — Imperial, California, United States
- Senior Clinical Trials — Laguna Hills, California, United States
- Shankle Clinic and Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
- Artemis Institute for Clinical Research — Riverside, California, United States
- Pacific Research Network, LLC — San Diego, California, United States
- Syrentis Clinical Research — Santa Ana, California, United States
- Mountain Neurological Research Center — Basalt, Colorado, United States
- Colorado Neurological Research Center, PC — Denver, Colorado, United States
- Ki Health Partners, LLC — Stamford, Connecticut, United States
- JEM Research Institute — Atlantis, Florida, United States
- Neurology Offices of South Florida — Boca Raton, Florida, United States
- K2 Medical Research- Ocoee — Clermont, Florida, United States
- Arrow Clinical Trials — Daytona Beach, Florida, United States
- Brain Matters Research — Delray Beach, Florida, United States
- MDFirst Research — Chandler, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.